title: What do I need to know about glycopeptide antibiotics?
abstract: Glycopeptides have been crucial in the fight against Gram-positive pathogens with their use within paediatrics becoming ever prevalent. This article reviews the pharmacology of the commonly used glycopeptides, vancomycin and teicoplanin, and discusses the practical aspects of their use in the clinical setting.
authors.affiliation: Derbyshire Children's Hospital, Derby, UK.|elizabeth.starkey@nhs.net.
authors.forename: S
authors.initials: S
authors.lastname: Li
authors.affiliation: Derbyshire Children's Hospital, Derby, UK.|elizabeth.starkey@nhs.net.
authors.forename: E S
authors.initials: ES
authors.lastname: Starkey
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D017334:Teicoplanin / Q000627:therapeutic use*; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D017334:Teicoplanin; D014640:Vancomycin
keywords: General Paediatrics; Pharmacology; Therapeutics; Toxicology